Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-227

"Are you on the pipe again? we are going into a phase 2 study straight of the bat....read the last release to the market you goose!"

You seem to have some comprehension difficulties.

Read what I wrote again carefully. It clearly speaks about starting from a Phase II trial. I'll reproduce it for you again below in larger print to make it easier to read.

In other words, based on historical data, there is more than a 77% chance BIT225 will fail somewhere along the road of trying to gain approval for Covid if it starts from Phase II studies.